Why Healthcare Should “Double-Down” on Exploring AI-powered BI for Reporting

Not understanding data often is the difference between success and failure.

  • Between positive and negative health outcomes.
  • Between improving and worsening patient satisfaction.
  • Between increasing or decreasing revenue.

Many areas in healthcare rely not only on the collection of data but, importantly, the ability to decipher and act upon it. In that intersection, reporting was born. After the advent of reporting, healthcare organizations looked to business intelligence to understand and act more quickly on the information created by data.

A new three-part article by MedeAnalytics President Scott Hampel focuses on reporting trends in healthcare. Learn why healthcare organizations must transition from manual reporting to AI-fueled predictive analytics.

Download the new chapter today.

Posted in

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

MedeAnalytics at HIMSS26: Turning Insight into Measurable Healthcare Performance

March 9-12, 2026   |   Venetian Convention & Expo Center   |   Las Vegas   As margin pressure intensifies and value-based care…

Read on...

Turning social risk into measurable financial performance

Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many…

Read on...

The GLP-1 Insights Series, Part 2: Maximizing impact and savings through analytics

GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers…

Read on...

The GLP-1 Insights Series, Part 1: Long-term impact on costs and outcomes for payers and providers

Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally…

Read on...